Arpita Pal

Arpita Pal is a Senior Scientist at Overland Pharmaceuticals since January 2023, following a role as a Scientist specializing in Engineered Cells at Synthego Corporation from January 2021 to November 2022. Arpita has extensive academic experience, having served as a Teaching and Mentoring professional at Purdue University from August 2013 to February 2020, where responsibilities included mentoring students and acting as a guest lecturer on topics related to microRNAs and epigenetics. Arpita's research experience includes a voluntary position at the Advanced Centre for Treatment, Research and Education in Cancer, where analysis focused on the BRCA1 gene, and a visiting research position at the University of Sheffield. Educational qualifications include a PhD in Cell/Cellular and Molecular Biology from Purdue University, a Master's in Molecular Medicine from the University of Sheffield, and a Bachelor's in Biotechnology from Sinhgad Technical Education Society's College of Science.